Back to Search
JOHN SELPH, MD
MD
Urology Physician
NPI: 1336383934IndividualAccepts Medicare
Education
OTHER
Class of 2009
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (5)
Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats.
PMID 18434589·J Pharmacol Exp Ther·2008
4-observational
Indanylidenes. 2. Design and synthesis of (E)-2-(4-chloro-6-fluoro-1-indanylidene)-N-methylacetamide, a potent antiinflammatory and analgesic agent without centrally acting muscle relaxant activity.
PMID 12540240·J Med Chem·2003
7-preclinical
Indanylidenes. 1. Design and synthesis of (E)-2-(4,6-difluoro-1-indanylidene)acetamide, a potent, centrally acting muscle relaxant with antiinflammatory and analgesic activity.
PMID 12540239·J Med Chem·2003
7-preclinical
Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases.
PMID 11504783·J Pharmacol Exp Ther·2001
7-preclinical
Effectiveness of GnRH plus prostaglandin F2alpha for estrus synchronization in cattle of Bos indicus breeding.
PMID 11219438·J Anim Sci·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 4601 CAROTHERS PKWY STE 475
FRANKLIN, TN 37067 - Phone
- (615) 790-1660
Quick Facts
- NPI
- 1336383934
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 17
- Clinical Trials
- 1
- Publications
- 5
Are you this provider?
Claim Your Profile